Schwartz wins PR accounts for three cancer treatment firms

Following on from its recent signing of melanoma vaccine client, Scancell, Schwartz Communications UK has signed three oncology accounts.

– UK-based Microsulis, which uses microwave technology to destroy previously inoperable tumours

– global health science company MDS Nordion which provides products and services used for the prevention, diagnosis and treatment of disease, specifically liver cancer treatments

– South Korea-based KAEL-GemVax, which is developing new cancer vaccines to enhance survival while maintaining a high quality of life for patients

[lnk|http://www.schwartzcomm.com|_blank|Schwartz Communications UK Limited]

New! Check out our Media Jobs board for PR and Journalism vacancies Learn more